Roche and CombiMatrix to Develop and Market Semiconductor-based Microarrays | GenomeWeb

In signing a 15-year development and marketing deal, Roche Diagnostics and biochip startup CombiMatrix are betting that semiconductor chips will prove as useful for DNA and protein expression analysis as they are for the computer industry.

The non-exclusive deal, which the companies signed July 3, stipulates that Roche will use, develop, and resell CombiMatrix''''s semiconductor-based biochips. The companies have also agreed to develop platform technology for standardized biochips.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.